| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594417 | American Heart Journal | 2017 | 10 Pages |
Abstract
This meta-analysis shows that in clinical trials, 54% of hyperkalemia cases were specifically related to the MRA treatment and 46% to other reasons. Therefore, non-MRA-related rises in potassium levels might be underestimated and should be rigorously explored before cessation of the evidence-based therapy with MRAs.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Davor VukadinoviÄ, Daniel MD, Aleksandra Nikolovska VukadinoviÄ, Bertram MD, Stefan MD, Michael MD,